Needle Biopsy Market Share, Growth and Trends Analysis By Type (Fine-Needle Aspiration Biopsy, Core Needle Biopsy, Vacuum-Assisted Biopsy, Image-Guided Biopsy), Utility (Disposable, Reusable), Applications (Tumor, Infection, Inflammation), Global Forecast to 2023
The Needle Biopsy Market is chiefly driven by product development and the fall in prices of raw materials and components. The increasing cases of cancers and growing usage of biopsy needles is driving the market. Companies should focus on improving the distribution efficiency to reduce the pressures on prices due to huge market fragmentation. Distributional agreements between large players and advanced products such as multilayer needles will be extremely beneficial. The emergence of needle biopsy is estimated to pose the greatest threat to the biopsy needle market.
Needle biopsy offers non-invasive diagnostic tests for detecting cancer as it used liquids such as blood, urine, saliva etc. to detect malignancy. Increasing automation will enhance the capabilities of needle biopsy and it may substitute the needle biopsy procedures. Real time progression of cancers is also possible in needle biopsy which raises the level of threat it possesses to needle biopsy. The falling cost of products due to greater market fragmentation and the emergence of Chinese companies is expected to put additional pressures on prices.
Request Free Sample Copy at: https://www.marketresearchfuture.com/sample_request/3830
In our estimates vacuum assisted needle biopsy will be the fastest growing segment. The increasing screening rates for cancers through the world will stimulate the market. Among the various cancers, breast cancer is expected to generate the largest use of needle biopsy. Needle Based Biopsy Guns is another lucrative strategy that is being pursued by many players. Core needle biopsy has a higher efficiency and detectability rate than fine needle aspiration biopsy. There is increasing bias to use core needle biopsy in combination with needle aspiration biopsy to achieve highest sensitivity and detectability. Thus, the two tests are complementary, and the effectiveness rate is highest with both tests are done together.
The growing stringent regulation and standards for medical devices, and the increasing uncertainty about reimbursement in the US are threatening the growth of the needle biopsy market.
Needle biopsy Market Players:
Key players profiled in the needle biopsy Industry report are Boston Scientific Corporation, Cook Medical, CareFusion Corporation, Hologic, Inc., and Cardinal Health, Inc., Medax, C. R. Bard, Inc., Möller Medical GmbH, Becton, Dickinson and Company, Hakko co. ltd., Kompass, Argon Medical Devices, Inc. and others.
Needle Biopsy Market Segmentation:
The global needle biopsy market is segmented based on type and applications. Based on type, the market has been segmented as fine-needle aspiration biopsy, core needle biopsy, vacuum-assisted biopsy and image-guided biopsy. Based on the utility, the market has been segmented as disposable and reusable. Based on the applications, the market has been segmented as tumor, infection, inflammation and others.
About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune – 411028
+1 646 845 9312